These results are based on the in silico docking study against different COVID-19 Proteins. The lowest Dock Score represents better binding to the specific receptor(protein) molecule.
Sr No | Ligand | Target | Binding Energy |
Docking Rank![]() |
Generic Name | Type | Name of Target | Name of Plant | Edit | Docking Score (General) |
---|---|---|---|---|---|---|---|---|---|---|
121 | DB00626 | 6lu7 | -6.70 | Bacitracin | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 121 | |||
122 | DB00403 | qhd43415_1 | -6.60 | Ceruletide | Ligand | Host translation inhibitor nsp1 | 122 | |||
123 | DB00290 | 6vsb | -5.40 | Bleomycin | Ligand | Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up | 123 | |||
124 | DB00014 | qhd43415_1 | -7.00 | Goserelin | Ligand | Host translation inhibitor nsp1 | 124 | |||
125 | DB00080 | 6lu7 | -6.00 | Daptomycin | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 125 | |||
126 | DB00626 | 6vsb | -6.30 | Bacitracin | Ligand | Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up | 126 | |||
127 | DB00106 | qhd43415_10 | -7.10 | Abarelix | Ligand | Non-structural protein 10 (nsp10) | 127 | |||
128 | DB00050 | 6vsb | -6.90 | Cetrorelix | Ligand | Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up | 128 | |||
129 | DB00512 | 6lu7 | -7.40 | Vancomycin | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 129 | |||
130 | DB00091 | 6vsb | -6.30 | Cyclosporine | Ligand | Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up | 130 | |||
131 | DB00364 | qhd43415_10 | -1.70 | Sucralfate | Ligand | Non-structural protein 10 (nsp10) | 131 | |||
132 | DB00602 | 6nur | -9.50 | Ivermectin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 132 | |||
133 | DB00569 | 6lu7 | -6.00 | Fondaparinux | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 133 | |||
134 | DB00035 | 6lu7 | -8.00 | Desmopressin | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 134 | |||
135 | DB00626 | qhd43415_1 | -5.30 | Bacitracin | Ligand | Host translation inhibitor nsp1 | 135 | |||
136 | DB00091 | 6nur | -7.30 | Cyclosporine | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 136 | |||
137 | DB00416 | 6vsb | -1.00 | Metocurine iodide | Ligand | Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up | 137 | |||
138 | DB00512 | qhd43415_10 | -6.20 | Vancomycin | Ligand | Non-structural protein 10 (nsp10) | 138 | |||
139 | DB00520 | 6lu7 | -6.10 | Caspofungin | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 139 | |||
140 | DB00027 | qhd43415_10 | -6.30 | Gramicidin D | Ligand | Non-structural protein 10 (nsp10) | 140 | |||
141 | DB00615 | 6nur | -9.10 | Rifabutin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 141 | |||
142 | DB00006 | 6nur | -8.10 | Bivalirudin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 142 | |||
143 | DB00035 | qhd43415_1 | -6.60 | Desmopressin | Ligand | Host translation inhibitor nsp1 | 143 | |||
144 | DB00091 | qhd43415_10 | -5.40 | Cyclosporine | Ligand | Non-structural protein 10 (nsp10) | 144 | |||
145 | DB00115 | qhd43415_10 | -7.10 | Cyanocobalamin | Ligand | Non-structural protein 10 (nsp10) | 145 | |||
146 | DB00290 | qhd43415_10 | -6.40 | Bleomycin | Ligand | Non-structural protein 10 (nsp10) | 146 | |||
147 | DB00362 | qhd43415_10 | -6.80 | Anidulafungin | Ligand | Non-structural protein 10 (nsp10) | 147 | |||
148 | DB00416 | 6lu7 | -0.90 | Metocurine iodide | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 148 | |||
149 | DB00512 | 6nur | -9.60 | Vancomycin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 149 | |||
150 | DB00569 | qhd43415_1 | -4.90 | Fondaparinux | Ligand | Host translation inhibitor nsp1 | 150 |